-
公开(公告)号：US11657905B2
公开(公告)日：2023-05-23
申请号：US17867160
申请日：2022-07-18
CPC分类号： G16H10/60 , G06K19/06028 , G06K19/06037 , G16H20/17 , G16H80/00
摘要： A patient platform for patient engagement and treatment compliance is disclosed. In an example, a system includes a clinician server, a personal mobile communication device storing first registration information for communicating with the clinician server, and a home therapy machine assigned to a patient and configured to transmit treatment information related to a dialysis treatment performed on the patient. The home therapy machine is capable of being communicatively coupled to the clinician server via a separate Internet connection as specified by second registration information and the personal mobile communication device via a local connection. The home therapy machine is configured to transmit the treatment information to the personal mobile communication device when the second registration information is not available or the separate Internet connection is not available. The personal mobile communication device is configured to transmit the received treatment information to the clinician server using the first registration information.
-
公开(公告)号：US10964417B2
公开(公告)日：2021-03-30
申请号：US16561273
申请日：2019-09-05
摘要： A patient platform for patient engagement and treatment compliance is disclosed. In an example, a processor is configured to obtain medical information from a patient for engagement and treatment compliance tracking. To obtain the medical information, the processor causes a user interface to be displayed with fields to be populated with medical information. After receiving a selection of a data field, the processor provides an option to enter medical information from an image. If the option is selected, the processor receives a recorded image of a medical device or a screen of a medical device, extracts text from the image, enables a selection of at least a portion of the text from the image, and writes the selected text from the image into the data field of the user interface as the medical information. The processor transmits the medical information to a patient medical record stored in a clinician database.
-
公开(公告)号：US12023427B2
公开(公告)日：2024-07-02
申请号：US17892395
申请日：2022-08-22
发明人： Justin Rohde , Derek Wiebenson
IPC分类号： A61M1/16
CPC分类号： A61M1/168 , A61M1/1682 , A61M1/1686 , A61M1/1688 , A61M1/169
摘要： A peritoneal dialysis apparatus includes a filter and a dialysis fluid circuit in fluid communication with the filter. The peritoneal dialysis apparatus also includes a pump for pumping fresh dialysis fluid to a peritoneum of a patient via the dialysis fluid circuit and pumping used dialysis fluid from the peritoneum of the patient through the dialysis fluid circuit and the filter. The peritoneal dialysis apparatus further includes a selective air access in fluid communication with the dialysis fluid circuit and a control unit configured to control the pump during a peritoneal dialysis treatment and a filter cleaning sequence. The control unit forms a fluid mixture during a filter cleaning sequence by opening the selective air access to mix air with a physiologically safe fluid. The fluid mixture is transferred across insides and/or outsides of the filter at least one time.
-
公开(公告)号：US20220395617A1
公开(公告)日：2022-12-15
申请号：US17892395
申请日：2022-08-22
发明人： Justin Rohde , Derek Wiebenson
IPC分类号： A61M1/16
摘要： A peritoneal dialysis apparatus includes a filter and a dialysis fluid circuit in fluid communication with the filter. The peritoneal dialysis apparatus also includes a pump for pumping fresh dialysis fluid to a peritoneum of a patient via the dialysis fluid circuit and pumping used dialysis fluid from the peritoneum of the patient through the dialysis fluid circuit and the filter. The peritoneal dialysis apparatus further includes a selective air access in fluid communication with the dialysis fluid circuit and a control unit configured to control the pump during a peritoneal dialysis treatment and a filter cleaning sequence. The control unit forms a fluid mixture during a filter cleaning sequence by opening the selective air access to mix air with a physiologically safe fluid. The fluid mixture is transferred across insides and/or outsides of the filter at least one time.
-
公开(公告)号：US12020788B2
公开(公告)日：2024-06-25
申请号：US18200263
申请日：2023-05-22
CPC分类号： G16H10/60 , G06K19/06028 , G06K19/06037 , G16H20/17 , G16H80/00
摘要： A platform for patient engagement and treatment compliance is disclosed. In an example, a system includes a home therapy machine configured to perform a renal failure therapy treatment. The system also includes a mobile communication device including an application having a calendar feature that identifies times/days in which the renal failure therapy treatment is scheduled to be performed. The application is configured to use the calendar feature to determine a time/day of a next scheduled renal failure therapy treatment. At a designated time before the next scheduled renal failure therapy treatment, the application causes a display interface of the personal mobile communication device to display a prompt for medical information. When the medical information is not received before the next scheduled renal failure therapy treatment, the application causes the home therapy machine to delay a start of the next scheduled renal failure therapy treatment.
-
公开(公告)号：US20210217502A1
公开(公告)日：2021-07-15
申请号：US17215979
申请日：2021-03-29
摘要： A patient platform for patient engagement and treatment compliance is disclosed. In an example, a home therapy machine of a patient is configured to transmit treatment information and a clinician database is configured to store a medical record and a registration file identifying the home therapy machine and a personal device of the patient as registered devices. The registration file also identifies whether the personal device installed an application for viewing the treatment information. A server is configured to store the treatment information to the medical record, receive an indication that the treatment information is to be displayed at the personal device, and determine from the registration file if the application is installed on the personal device. If the application is not installed, the server converts the treatment information to text message or Short Messaging Service (“SMS”) format for transmission.
-
7.发明公开公开(公告)号：US20230290458A1
公开(公告)日：2023-09-14
申请号：US18200263
申请日：2023-05-22
CPC分类号： G16H10/60 , G16H20/17 , G16H80/00 , G06K19/06028 , G06K19/06037
摘要： A platform for patient engagement and treatment compliance is disclosed. In an example, a system includes a home therapy machine configured to perform a renal failure therapy treatment. The system also includes a mobile communication device including an application having a calendar feature that identifies times/days in which the renal failure therapy treatment is scheduled to be performed. The application is configured to use the calendar feature to determine a time/day of a next scheduled renal failure therapy treatment. At a designated time before the next scheduled renal failure therapy treatment, the application causes a display interface of the personal mobile communication device to display a prompt for medical information. When the medical information is not received before the next scheduled renal failure therapy treatment, the application causes the home therapy machine to delay a start of the next scheduled renal failure therapy treatment.
-
公开(公告)号：US20220351812A1
公开(公告)日：2022-11-03
申请号：US17867160
申请日：2022-07-18
摘要： A patient platform for patient engagement and treatment compliance is disclosed. In an example, a system includes a clinician server, a personal mobile communication device storing first registration information for communicating with the clinician server, and a home therapy machine assigned to a patient and configured to transmit treatment information related to a dialysis treatment performed on the patient. The home therapy machine is capable of being communicatively coupled to the clinician server via a separate Internet connection as specified by second registration information and the personal mobile communication device via a local connection. The home therapy machine is configured to transmit the treatment information to the personal mobile communication device when the second registration information is not available or the separate Internet connection is not available. The personal mobile communication device is configured to transmit the received treatment information to the clinician server using the first registration information.
-
公开(公告)号：US20220184284A1
公开(公告)日：2022-06-16
申请号：US17682659
申请日：2022-02-28
发明人： Neil Tiwari , Joshua James Miller , Marc Steven Minkus , Matthew R. Muller , Derek Wiebenson , Douglas L. Wilkerson , Timothy G. Robinson , Anders J. Wellings , Kathryn Louise Hansbro , Borut Cizman , Brian S. Kunzeman , Robin D. Cooper , Timothy L. Kudelka , Angelo A. Sarto , Steve Joseph Lindo , Jostein Baustad , Duston Mounts , Shafali Hill
IPC分类号： A61M1/14 , A61M1/28 , G06F8/65 , G16H40/63 , G16H40/40 , G16H10/60 , G06Q30/06 , A61M1/16 , A61M1/34 , A61M1/36 , G16H20/17 , G16H20/40 , G16H40/67 , G16H20/10
摘要： A renal therapy system is disclosed. In an example, the renal therapy system includes a user interface device, such as a tablet computer. The renal therapy system also includes a renal therapy machine configured to perform a renal therapy. The renal therapy machine includes a data transfer interface configured to communicatively couple to the user interface device, a dialysis fluid pump, and a processor that operates a connectivity agent having an activated mode and a deactivated mode. When in the activated mode, the connectivity agent enables the processor to send data related to a performance of the renal therapy to a system hub. In the deactivated mode, the processor is prevented from sending the data to or receiving any data from the system hub. The user interface device is configured to receive data from and send data to the processor regardless of a status of the connectivity agent.
-
公开(公告)号：US10463775B2
公开(公告)日：2019-11-05
申请号：US15980387
申请日：2018-05-15
发明人： Justin Rohde , Derek Wiebenson
IPC分类号： A61M1/16
摘要： A renal therapy apparatus includes a blood filter, a blood pump, a treatment fluid pump, and a control unit configured to control at least one of the blood pump or the treatment fluid pump during a filter cleaning sequence. In a first phase of the filter cleaning sequence, a first fluid including a blood-compatible and physiologically safe fluid is transferred back and forth across the insides and/or outsides of the blood filter. After the first phase, a second fluid is formed by mixing the first fluid with air. In a second phase of the filter cleaning sequence, the second fluid is transferred across the insides and/or outsides of the blood filter at least one time.
-
-
-
-
-
-
-
-
-
搜索结果
34 条记录 (耗时 0.018 秒)
